ARLINGTON, Virginia., November 4, 2021 / PRNewswire / – Science and Medicine Group, the company behind Instrument Business Outlook, Kalorama Information, SDi and other publications, announces the publication of In Vitro Diagnostics Business Outlook, which focuses on the activities of clinical tests.
“No one needs to be told how important in vitro diagnostics are anymore,” said Bruce Carlson, senior vice president of publications for the Science and Medicine group. “The COVID-19 pandemic has made it clear that early testing prevents disease. But the pace of the diagnostic industry has accelerated, and there is a need to regularly update and assess the market. “
This new bimonthly publication dedicated to the IVD market, In Vitro Diagnostics Business Outlook offers:
- Market sizing and forecasting of IVD market segments in each issue
- Clinical Chemistry, Infectious Disease Screening, Oncology, Hematology, Blood Bank, Coagulation, Point of Care – Updates on Important Test Categories You Need to Know
- Industry watch – Developments with COVID-19 and other tests
- M&A, Distribution, Tracked and Approved Partnerships
- New product presentations and company announcements
- Company Profiles and Quarterly Results Summaries
- Regional market coverage
Unique features of this new newsletter include market analysis in each issue and a chart that tracks significant transactions – including mergers and technology partnerships in the IVD industry.
“What our customers have told us is that the market research reports are great but require more frequent updates,” Carlson said. “Outlook is designed for that. “
In Vitro Diagnostics Business Outlook is designed to deliver the most relevant news. News that could affect short-term business decisions is included. In Vitro Diagnostics Business Outlook also explains the relevant science behind partnerships, product launches and trade agreements.
Science and Medicine Group also publishes the bimonthly Instrument Business Outlook and Cell and Gene Therapy Business Outlook newsletter.
Information is available at: www.invitrodiagnosticsbusinessoutlook.com
About the Science and Medicine Group
Science and Medicine Group supports companies seeking to bring products to market for the rapidly changing market at the intersection of science, medicine and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging and clinical diagnostic companies by helping them create strategies and products to win markets and deliver platforms to digitally engage their markets through a variety of innovative solutions. Our clients, including some of the largest Fortune 500 companies in the world, use our business intelligence, market research, publications and marketing platforms to grow their businesses globally.
SOURCE Science and Medicine Group Inc